Currently, the NGI Center serves as a hub for several affiliated labs that each approach Alzheimer disease or other neurodegenerative disease for a different angle. Explore the sites below to see what expertise is available through the NGI.

Neurogenomics and Informatics Center Faculties includes PIs that are located on the NGI space at the 4444 Forest Park Ave.

NGI affiliated lab includes any faculty using high-throughput omic data to understand the pathobiology of human with focus on leverage human samples to study neurodegenerative diseases. There is no cost to join, but there are many benefits to becoming an NGI Center Affiliated lab member.

NGI Faculty

Currently, the NGI Center serves as a hub for several affiliated labs that each approach Alzheimer disease or other neurodegenerative disease for a different angle. Explore the sites below to see what expertise is available through the NGI.

Carlos Cruchaga

Specializes in the use of multi-omic technologies across multiple tissue types to deeply characterize neurodegenerative diseases for the identification of biomarkers and therapeutics. Cruchaga Lab

Oscar Harari

Interrogation of large phenotypic, genomic, transcriptomic and proteomic datasets of neurodegenerative diseases to identify molecular profiles that provide novel insight into altered pathways associated with disease etiology and progression.

Harari lab Website

Victoria Fernandez

Investigates -omic technologies to identify common, altered pathways among the three main AD etiologies (ADAD, EOAD, and LOAD) and uses iPSC and 3D models to interrogate novel findings and their potential as therapeutic targets in the context of Alzheimer’s disease.

Laura Ibanez

Developing minimally invasive tools for rapid and accurate diagnosis of neurodegenerative diseases during pre-symptomatic phases and prediction of outcomes during the acute phase of ischemic strokes.

Ibanez Lab

Yun Ju Sung

Using multi-tissue multi-omics data in Alzheimer’s disease to identify sex-specific risk genes, prediction models and druggable targets

Sung